Advertisement
U.S. markets closed
Advertisement

Dabur India Limited (DABUR.NS)

NSE - NSE Real Time Price. Currency in INR
547.00+5.85 (+1.08%)
At close: 03:30PM IST
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
Previous Close541.15
Open544.90
Bid0.00 x 0
Ask0.00 x 0
Day's Range541.70 - 548.90
52 Week Range503.65 - 610.75
Volume2,125,548
Avg. Volume1,625,655
Market Cap969.306B
Beta (5Y Monthly)0.23
PE Ratio (TTM)55.25
EPS (TTM)9.90
Earnings DateJan 31, 2024 - Feb 05, 2024
Forward Dividend & Yield5.50 (1.02%)
Ex-Dividend DateNov 10, 2023
1y Target Est605.30
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for DABUR.NS

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Reuters

      UPDATE 1-Dabur India's two units dismissed as defendants in hair relaxer lawsuit in US

      Dabur India said on Wednesday a U.S. court had dismissed two of its three subsidiaries as defendants in a lawsuit tying the use of hair relaxer products to ovarian and uterine cancers as well as other health issues. as defendants "for lack of personal jurisdiction" as neither was involved in manufacturing, marketing, distributing or selling hair relaxer products in the United States, the company said in a late filing on Wednesday. However, Dabur's unit Namaste Laboratories continues to be a defendant along with many other industry players such as L'Oreal, Revlon, Luster Products and Avion Industries among others, it added.

    • Reuters

      Dabur India's units face lawsuits in US, Canada alleging products caused cancer

      The consumer goods firm said about 5,400 cases against several companies including its subsidiaries, Namaste Laboratories, Dermoviva Skin Essentials and Dabur International, have been consolidated as a multi-district litigation before a U.S. District Court in Illinois. The units have denied liability and have retained counsel to defend them, the company said.

    • Reuters

      Dabur India units face lawsuits in US, Canada alleging products caused cancer

      The consumer goods firm said about 5,400 cases against several companies including its subsidiaries, Namaste Laboratories, Dermoviva Skin Essentials and Dabur International, have been consolidated as a multi-district litigation before a U.S. District Court in Illinois. Dabur India, which sells Vatika Shampoo and Honitus cough syrup brands, said it could not determine the financial implication due to settlement or verdict outcome at this stage but expected the defense costs to breach the materiality threshold in the near future.